|
2026 Journal Article The impact of dysphagia on carers of people with head and neck cancer: development and preliminary validation of the significant other scale for eating in head and neck cancer (SOSE-H&N)Packer, Rebecca L., Wishart, Laurelie R., Brown, Bena, Patterson, Joanne, Watson, Laura-Jayne, Hutchison, Alana, Iyo, Jasmin Jie Min, Scarinci, Nerina, Ward, Elizabeth C. and Porceddu, Sandro V. (2026). The impact of dysphagia on carers of people with head and neck cancer: development and preliminary validation of the significant other scale for eating in head and neck cancer (SOSE-H&N). Disability and Rehabilitation, ahead-of-print (ahead-of-print) PMID 9207179, 1-16. doi: 10.1080/09638288.2025.2594575 |
|
2025 Journal Article Comparison of prophylactic versus reactive tube feeding approaches on weight loss and unplanned hospital admissions in patients with head and neck cancer receiving chemoradiotherapyBrown, Teresa, Cooney, Louise, Smith, David, Elvin-Walsh, Louise, Kern, Eliza, Ahern, Suzanne, Brown, Bena, Hickman, Ingrid, Porceddu, Sandro, Kenny, Lizbeth and Hughes, Brett (2025). Comparison of prophylactic versus reactive tube feeding approaches on weight loss and unplanned hospital admissions in patients with head and neck cancer receiving chemoradiotherapy. Current Oncology, 33 (1) 5. doi: 10.3390/curroncol33010005 |
|
2025 Journal Article Response-adapted surgical and radiotherapy de-escalation in resectable cutaneous squamous cell cancer using pembrolizumab: the De-Squamate studyLadwa, Rahul, Lee, Jenny H., McGrath, Margaret, Cooper, Caroline, Liu, Howard, Bowman, James, Gupta, Ruta, Cuscaden, Claire, Nottage, Michelle, Clark, Jonathan R., Le, Dieu, Pauley, Marketa, Kulasinghe, Arutha, Gonzalez-Cruz, Jazmina, Porceddu, Sandro V., Hughes, Brett G.M. and Panizza, Benedict (2025). Response-adapted surgical and radiotherapy de-escalation in resectable cutaneous squamous cell cancer using pembrolizumab: the De-Squamate study. Journal of Clinical Oncology, 43 (26) JCO-25-00387, 2888-2896. doi: 10.1200/jco-25-00387 |
|
2025 Conference Publication Phase 3 trial of adjuvant cemiplimab (cemi) versus placebo (pbo) for high-risk cutaneous squamous cell carcinoma (CSCC)Rischin, Danny, Porceddu, Sandro V., Day, Fiona, Brungs, Daniel, Christie, Hayden Robert, Jackson, James Estes, Stein, Brian N., Su, Yungpo, Adams, Gerard, Bowyer, Samantha, Otty, Zulfiquer Ali, Yamazaki, Naoya, Bossi, Paolo, Challapalli, Amarnath, Ladwa, Rahul, Hauschild, Axel, Seebach, Frank A., Yoo, Suk-Young, Goncalves, Priscila Hermont and Fury, Matthew G. (2025). Phase 3 trial of adjuvant cemiplimab (cemi) versus placebo (pbo) for high-risk cutaneous squamous cell carcinoma (CSCC). 2025 ASCO Annual Meeting, Chicago, IL United States, 30 May - 3 June 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.16_suppl.6001 |
|
2025 Journal Article Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causesCampbell, Belinda A., Baade, Peter D., Dasgupta, Paramita, Cameron, Jessica K., Porceddu, Sandro V., Prince, H. Miles and Thursky, Karin (2025). Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes. British Journal of Dermatology, 192 (6), 1018-1028. doi: 10.1093/bjd/ljae476 |
|
2025 Journal Article Hypofractionated adjuvant radiotherapy in cutaneous squamous cell and basal cell carcinoma of the head and neck: 50(Gy) in 20 studyHu, Marcus, Liu, Howard, Bernard, Anne, Efendy, Michael and Porceddu, Sandro V. (2025). Hypofractionated adjuvant radiotherapy in cutaneous squamous cell and basal cell carcinoma of the head and neck: 50(Gy) in 20 study. Oral Oncology Reports, 13 100732. doi: 10.1016/j.oor.2025.100732 |
|
2025 Journal Article Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024Campbell, Belinda A., Prince, H. Miles, Thursky, Karin, Dabaja, Bouthaina, Hoppe, Richard, Specht, Lena, Morris, Stephen and Porceddu, Sandro V. (2025). Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024. Seminars in Radiation Oncology, 35 (1), 110-125. doi: 10.1016/j.semradonc.2024.08.005 |
|
2025 Journal Article Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter studyEbrahimi, Ardalan, Gupta, Ruta, McDowell, Lachlan, Magarey, Matthew J. R., Smith, Paul N., Schulte, Klaus-Martin, Perriman, Diana M., Veness, Michael, Porceddu, Sandro, Low, Tsu-Hui Hubert, Fowler, Allan and Clark, Jonathan R. (2025). Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study. Head and Neck, 47 (1), 254-262. doi: 10.1002/hed.27912 |
|
2024 Journal Article Determinants of prognosis in head and neck cutaneous squamous cell carcinoma with nodal metastasesEbrahimi, Ardalan, Gupta, Ruta, McDowell, Lachlan, Magarey, Matthew J. R., Smith, Paul N., Schulte, Klaus-Martin, Perriman, Diana M., Veness, Michael, Porceddu, Sandro, Low, Tsu-Hui Hubert, Fowler, Allan and Clark, Jonathan R. (2024). Determinants of prognosis in head and neck cutaneous squamous cell carcinoma with nodal metastases. Jama Otolaryngology-Head and Neck Surgery, 150 (11), 986-994. doi: 10.1001/jamaoto.2024.3103 |
|
2024 Journal Article A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinomaLadwa, Rahul, Chandra, Janin, Woo, Wai-Ping, Finlayson, Neil, Liu, Howard, McGrath, Margaret, See, Adrienne, Hughes, Brett G., Cooper, Caroline L., Jackson, Jim E., Dzienis, Marcin, Xu, Yan, Panizza, Benedict, Frazer, Ian and Porceddu, Sandro V. (2024). A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. Frontiers in Oncology, 14 1419258, 1-8. doi: 10.3389/fonc.2024.1419258 |
|
2024 Conference Publication A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicityPanizza, Benedict J., O'Leary, Stephen John, Hart, Christopher David, Diwakarla, Chandra Sai, Barnett, Catherine, Lapuerta, Pablo, Lee, John, Raines, Shane, Quigley, Tera, Wolff, Heather M., Keilty, John, Ladwa, Rahul, Porceddu, Sandro V., McGrath, Margaret, Seetharamu, Nagashree, Fua, Tsien and Rischin, Danny (2024). A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicity. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.6100 |
|
2024 Journal Article Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in QueenslandPorceddu, Sandro, Negrello, Theresa, Rawson, Neal, Dunn, Nathan, Batstone, Martin, Collins, Michael, Dowthwaite, Sam, Hughes, Brett G. M., Kenny, Liz, Ladwa, Rahul, Panizza, Ben and Cossio, Danica (2024). Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in Queensland. Journal of Medical Imaging and Radiation Oncology, 68 (4), 472-480. doi: 10.1111/1754-9485.13643 |
|
2024 Journal Article Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancerYoung, Richard J., Angel, Christopher, Bressel, Mathias, Pizzolla, Angela, Thai, Alesha A., Porceddu, Sandro V., Liu, Howard, Idrizi, Rejhan, Metta, Jana, Lim, Annette M., Solomon, Benjamin J. and Rischin, Danny (2024). Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer. Oral Oncology, 150 106687, 106687. doi: 10.1016/j.oraloncology.2024.106687 |
|
2023 Conference Publication High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC studyLadwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278 |
|
2023 Journal Article Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus–Associated Oropharyngeal Cancer: A TROG 12.01 Secondary AnalysisMcDowell, Lachlan, Bressel, Mathias, King, Madeleine T., Corry, June, Kenny, Lizbeth, Porceddu, Sandro, Wratten, Christopher, Macann, Andrew, Jackson, James E. and Rischin, Danny (2023). Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus–Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis. International Journal of Radiation Oncology Biology Physics, 116 (5), 1110-1125. doi: 10.1016/j.ijrobp.2023.02.041 |
|
2023 Conference Publication A proteomic signature associated with prognosis in HPV-related locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)Liu, Jia (Jenny), Jackson, Christopher, Anees, Asim, Noor, Zainab, Williams, Steven, Porceddu, Sandro, Liu, Howard, Ladwa, Rahul, Whitfield, Joseph, Reddel, Roger R., Zhong, Qing, Panizza, Benedict J. and Robinson, Phillip J (2023). A proteomic signature associated with prognosis in HPV-related locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.6055 |
|
2023 Book Chapter Regional radiotherapy in head and neck non-melanoma skin cancer Smith, Justin and Porceddu, Sandro V. (2023). Regional radiotherapy in head and neck non-melanoma skin cancer . Radiotherapy in skin cancer: a practical guide on indications and techniques. (pp. 145-152) edited by Kurian Jones Joseph, Michael J. Veness, Elizabeth Barnes and Agata Rembielak. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-031-44316-9_14 |
|
2023 Journal Article The Current Treatment Landscape of Cutaneous Squamous Cell CarcinomaChong, Chia Yuen, Goh, Michelle S., Porceddu, Sandro V., Rischin, Danny and Lim, Annette M. (2023). The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma. American Journal of Clinical Dermatology, 24 (1), 25-40. doi: 10.1007/s40257-022-00742-8 |
|
2022 Journal Article HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancerMehdi, Ahmed M., Zhou, Chenhao, Turrell, Gavin, Walpole, Euan, Porceddu, Sandro, Frazer, Ian H. and Chandra, Janin (2022). HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer. Cancer Gene Therapy, 30 (4), 1-12. doi: 10.1038/s41417-022-00577-9 |
|
2022 Conference Publication High-dimensional spatial phenotyping of cutaneous squamous cell carcinoma from immune-competent and immunocompromised patientsKulasinghe, Arutha, Jhaveri, Niyati, Klymyshyn, Dmytro, Cheikh, Bassem Ben, Ladwa, Rahul, Liu, Howard, Cooper, Caroline, Belz, Gabrielle, Porceddu, Sandro and Braubach, Oliver (2022). High-dimensional spatial phenotyping of cutaneous squamous cell carcinoma from immune-competent and immunocompromised patients. SITC 37th Annual Meeting (SITC 2022), Boston, MA United States, 8–12 November 2022. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2022-sitc2022.0079 |
